Disc Medicine Inc
(IRON)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -151,653 | -89,332 | -34,085 | -109,357 | -79,900 |
| Depreciation Amortization | -6,695 | -5,043 | -2,507 | -5,148 | -2,945 |
| Accounts payable and accrued liabilities | -680 | -1,598 | -1,277 | -4,681 | -9,076 |
| Other Working Capital | -4,869 | -11,198 | -11,481 | 3,231 | 3,729 |
| Other Operating Activity | 26,804 | 17,877 | 7,974 | 22,029 | 21,839 |
| Operating Cash Flow | $-137,093 | $-89,294 | $-41,376 | $-93,926 | $-66,353 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -913 | -887 | -851 | -505 | -56 |
| Purchase Of Investment | -491,312 | -405,876 | -347,250 | -386,627 | -313,850 |
| Sale Of Investment | 320,819 | 185,819 | 75,468 | 94,800 | 23,000 |
| Investing Cash Flow | $-171,406 | $-220,944 | $-272,633 | $-292,332 | $-290,906 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 28,988 | N/A |
| Common Stock Issued | 256,153 | 244,856 | 243,964 | 190,719 | 189,076 |
| Other Financing Activity | 578 | 287 | 287 | -1,393 | 441 |
| Financing Cash Flow | $256,731 | $245,143 | $244,251 | $218,314 | $189,517 |
| Beginning Cash Position | 192,672 | 192,672 | 192,672 | 360,616 | 360,616 |
| End Cash Position | 140,904 | 127,577 | 122,914 | 192,672 | 192,874 |
| Net Cash Flow | $-51,768 | $-65,095 | $-69,758 | $-167,944 | $-167,742 |
| Free Cash Flow | |||||
| Operating Cash Flow | -137,093 | -89,294 | -41,376 | -93,926 | -66,353 |
| Capital Expenditure | -913 | -887 | -851 | -505 | -56 |
| Free Cash Flow | -138,006 | -90,181 | -42,227 | -94,431 | -66,409 |